GeneOne Life Science, Inc. (KRX:011000)

GeneOne Life Science Revenue

GeneOne Life Science had revenue of 2.06B KRW in the quarter ending June 30, 2026, a decrease of -69.82%. This brings the company's total for the last twelve months to 12.37B, down -64.38% year-over-year. In the year 2025, GeneOne Life Science had annual revenue of 23.04B, down -35.49%. That makes GeneOne Life Science the 37,713th largest company in the world by revenue and 2,400th in South Korea.

• Revenue (ttm): 12.37B
• Revenue Growth: -64.38%
• P/S Ratio: 3.92
• Revenue / Employee: 412.18M
• Employees: 30
• Market Cap: 48.42B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Business 11.97B 51.9%
• Fabric Business 11.07B 48.1%

By Geography

Chart

• Overseas 20.13B 87.3%
• South Korea 2.92B 12.7%

Fiscal year ended Dec 31, 2025 See the full GeneOne Life Science breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	23.04B	-12.68B	-35.49%
Dec 31, 2024	35.72B	-4.48B	-11.15%
Dec 31, 2023	40.20B	-8.52B	-17.48%
Dec 31, 2022	48.72B	10.02B	25.89%
Dec 31, 2021	38.70B	-2.80B	-6.75%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error